Next Issue
Volume 8, 02
Previous Issue
Volume 7, 12
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
0.4
Journals
Cardiovascular Medicine
Volume 8
Issue 1
cardiovascmed-logo

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement
Cardiovascular Medicine is published by MDPI from Volume 28 Issue 1 (2025). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Editores Medicorum Helveticorum (EMH).

Cardiovasc. Med., Volume 8, Issue 1 (01 2005) – 8 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
4 pages, 177 KB  
Editorial
No Peace with PEACE: Wie Protektiv Sind Angiotensin-Converting-Enzym-Inhibitoren?
by Thomas F. Lüscher and Roberto Corti
Cardiovasc. Med. 2005, 8(1), 6; https://doi.org/10.4414/cvm.2005.01073 - 28 Jan 2005
Viewed by 47
Abstract
Als Robert Tigerstedt, ein finnischer Physiologe, welcher am Karolinska Institut in Stockholm arbeitete, im Jahr 1896 Hunden Extrakte aus homogenisierten Nieren infundierte [1], war er sich der enormen Bedeutung seines Experimentes wohl zunächst nicht bewusst [...] Full article
►▼ Show Figures

Figure 1

2 pages, 138 KB  
Communication
Rapport Annuel 2003 du Groupe de Travail Stimulateurs Cardiaques et Electrophysiologie
by S. Osswald, J. Fuhrer, J.-L. Crevoisier, I. Babotai, U. Bauersfeld, H.O. Gloor, J. Schläpfer and J. Sztajzel
Cardiovasc. Med. 2005, 8(1), 29; https://doi.org/10.4414/cvm.2005.01069 - 28 Jan 2005
Viewed by 36
Abstract
La statistique détaillée peut être consultée sous l’Internet www.pacemaker.ch [...] Full article
2 pages, 134 KB  
Communication
Rapport Annuel 2003 du Groupe de Travail Biologie Cardiovasculaire
by Daniel Hayoz, François Mach, Thomas Suter and Christian Matter
Cardiovasc. Med. 2005, 8(1), 27; https://doi.org/10.4414/cvm.2005.01070 - 28 Jan 2005
Viewed by 40
Abstract
Activités du Groupe de Travail: Le Groupe de Travail Biologie Cardiovasculaire en association avec l’AGLA a organisé dans le cadre du congrès de la Société Suisse de Cardiologie, qui s’est tenu en mai à Lausanne, un atelier sur le thème Angiogenèse et [...] Read more.
Activités du Groupe de Travail: Le Groupe de Travail Biologie Cardiovasculaire en association avec l’AGLA a organisé dans le cadre du congrès de la Société Suisse de Cardiologie, qui s’est tenu en mai à Lausanne, un atelier sur le thème Angiogenèse et Athérosclérose [...] Full article
2 pages, 339 KB  
Interesting Images
Eine Rechtsschenkelblock-Tachykardie
by Beat Schär and Stefan Osswald
Cardiovasc. Med. 2005, 8(1), 25; https://doi.org/10.4414/cvm.2005.01068 - 28 Jan 2005
Viewed by 30
Abstract
Bei einem 32jährigen Mann traten vor allem bei Anstrengungen wiederholt lang anhaltende Tachykardien auf, weshalb er hospitalisiert werden musste [...] Full article
2 pages, 450 KB  
Interesting Images
Persistent Elevated Jugular Venous Pressure and Pleural Effusion Following Myoardial Infarction
by M. Zuber, V. Briner, B. Allgayer and Paul Erne
Cardiovasc. Med. 2005, 8(1), 23; https://doi.org/10.4414/cvm.2005.01071 - 28 Jan 2005
Viewed by 30
Abstract
Case report: A fourtynine-year-old man without clinical symptoms nor relevant illnesses prior to the hospitalisation was admitted due to a large anteroseptal and apical infarct and presented with biventricular dysfunction. During followup ejection fraction of the patient with one vessel disease rose [...] Read more.
Case report: A fourtynine-year-old man without clinical symptoms nor relevant illnesses prior to the hospitalisation was admitted due to a large anteroseptal and apical infarct and presented with biventricular dysfunction. During followup ejection fraction of the patient with one vessel disease rose from 31 to 45% within four weeks following percutaneous revascularisation of an occluded middle left anterior descending artery (LAD) by use of a stent[...] Full article
5 pages, 164 KB  
Editorial
Rimonabant—Ein Cannabinoid-Rezeptor-Antagonist zur Gewichtsreduktion und Rauchentwöhnung
by Lukas Spieker, Riccardo Stacchi, Roberto Corti and Georg Noll
Cardiovasc. Med. 2005, 8(1), 18; https://doi.org/10.4414/cvm.2005.01066 - 28 Jan 2005
Viewed by 40
Abstract
Treatment of lifestyle risk factors such as and smoking is difficult. These risk factors play important roles in cardiovascular disease. Current therapeutic strategies only have minor impact on associated metabolic changes such as low HDL cholesterol and insulin resistance. Rimonabant is a novel [...] Read more.
Treatment of lifestyle risk factors such as and smoking is difficult. These risk factors play important roles in cardiovascular disease. Current therapeutic strategies only have minor impact on associated metabolic changes such as low HDL cholesterol and insulin resistance. Rimonabant is a novel compound of the class of the cannabinoid receptor antagonists blocking CB1 receptors. Clinical studies demonstrate its efficacy in the treatment of obese patients. Several clinical studies show a consistent weight reduction of around 7 kg with rimonabant which is maintained over the followup period of two years. Improved lipid profile (increased HDL cholesterol, +25%) and the reduction of inflammatory markers promise interesting results in upcoming morbidity and mortality trials. Besides, rimonabant is helpful in smoking cessation. The proportion of patients free from smoking was almost doubled by rimonabant (28% vs. 16% in the placebo group). Weight increase was avoided in rimonabant- treated patients whereas those in the placebo group slightly gained weight. Full article
►▼ Show Figures

Figure 1

3 pages, 192 KB  
Editorial
No PEACE for ACE Inhibitors
by Christophe Wyss, Johannes Holzmeister and Jens P. Hellermann
Cardiovasc. Med. 2005, 8(1), 15; https://doi.org/10.4414/cvm.2005.01072 - 28 Jan 2005
Viewed by 33
Abstract
Hintergrund: Nach Gabe eines ACE-Hemmers konnte in randomisierten klinischen Studien eine reduzierte Mortalität und Morbidität bei Patienten mit symptomatischer und asymptomatischer Herzinsuffizienz und systolischer Funktionsstörung nachgewiesen werden [...] Full article
►▼ Show Figures

Figure 1

3 pages, 1143 KB  
Case Report
Risky Conversion: Torsades de Pointes bei Vorhofflattern
by M. Lehky Hagen, S. V. Aschkenasy, D. Keller, S. Marsch and Patrick Hunziker
Cardiovasc. Med. 2005, 8(1), 12; https://doi.org/10.4414/cvm.2005.01067 - 28 Jan 2005
Viewed by 33
Abstract
Fallbeschreibung: Ein 64jähriger Hypertoniker konsultiert seinen Hausarzt wegen akuter Dyspnoe[...] Full article
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-8
Previous Issue
Next Issue
Back to TopTop